Bayer & Monsanto v. Duffy: $989K Judgment for GM Soybean Patent Infringement
Bayer AG and Monsanto Technology LLC secured a summary judgment of $989,752.50 against farmer Caleb Duffy for willful infringement of two GM soybean biotechnology patents and breach of Technology Stewardship Agreements across three consecutive crop years. The court also imposed a permanent injunction and awarded attorney fees.
Willful GM Seed Infringement Over Three Seasons Ends in Six-Figure Judgment
Filed in January 2023 in the Eastern District of Missouri, this action pitted agricultural biotech giants Bayer AG and Monsanto Technology LLC against individual farmer Caleb Duffy. The plaintiffs asserted two core biotechnology patents — US7838729B2, covering the soybean event MON89788 detection methods, and US9944945B2, covering chloroplast transit peptides for DMO targeting — together underpinning the Roundup Ready 2 Xtend soybean platform. The case alleged that Duffy knowingly saved, planted, and used patented seed without authorisation across the 2020, 2021, and 2022 growing seasons.
Judge John A. Ross granted summary judgment in favour of Bayer CropScience LP and Monsanto Technology LLC, finding Duffy liable for both knowing and wilful patent infringement and for breaching the Technology Stewardship Agreements (TSAs) he had signed for each of the three seasons. The court entered liquidated damages of $989,752.50 — consistent with pre-agreed TSA damages provisions — and imposed a permanent injunction barring Duffy from making, using, saving, planting, or transferring any seed containing the plaintiffs’ patented biotechnologies without written permission. The injunction also prohibits unapproved dicamba herbicide applications to Xtend crops.
The 814-day duration reflects a case that moved through discovery and motion practice without trial, consistent with a fact pattern where contractual admissions via the TSAs limited Duffy’s viable defences. The willfulness finding is notable: it suggests Duffy had clear notice of the IP restrictions, which typically strengthens a fee entitlement claim. Attorney fees were awarded per TSA terms, though quantum remains subject to further proceedings. What drove any settlement discussions — if any occurred — is not visible from the public docket.
Filing to Judgment on the merits for Plaintiff in 814 days
814 days from filing to judgment — typical for a summary judgment disposition in a district patent case
Summary judgment for Bayer & Monsanto: what the ruling means for both parties
Summary judgment on willful infringement — no trial needed
The court granted summary judgment, meaning no genuine dispute of material fact existed on either the infringement or breach-of-contract claims. The willfulness finding indicates Duffy had actual knowledge of the patent rights and TSA restrictions yet continued the conduct across multiple seasons. Under 35 U.S.C. § 284, willful infringement can support enhanced damages, though the court here awarded liquidated damages per the TSA formula rather than judicially enhanced damages.
Summary judgment · Willful infringementFull damages, permanent injunction, and attorney fees secured
Bayer and Monsanto obtained every major form of relief available: $989,752.50 in liquidated damages (pre-agreed in the TSAs, avoiding the need to prove lost profits), a permanent injunction covering all current and future use of the patented biotech seeds, and an attorney fee award. The permanent injunction is particularly significant — it binds Duffy prospectively and any future breach would constitute contempt. The TSA-based fee entitlement removes the ‘exceptional case’ hurdle under 35 U.S.C. § 285.
Injunction · Liquidated damages · Fee awardSix-figure judgment, injunction, and fee exposure for an individual farmer
Duffy faces a $989,752.50 judgment, a permanent injunction on his farming operations involving Xtend seed technology, and an unquantified attorney fee liability. For an individual agricultural operator, this is a commercially devastating outcome. The willfulness finding closes off equitable arguments on appeal and leaves little headroom for damages reduction. The TSA’s liquidated damages clause — signed voluntarily — removed the plaintiff’s burden to prove actual harm, making the damages quantum largely uncontestable.
Judgment · Permanent injunction · Fee liabilityStrong precedent for seed company IP enforcement via TSA mechanisms
This outcome reinforces that Technology Stewardship Agreements function as powerful dual-purpose instruments: contractual enforcement tools and patent licensing proxies. The court’s acceptance of TSA liquidated damages provisions removes the need to quantify actual harm — a significant evidentiary advantage for seed IP holders. R&D and IP teams in agricultural biotech should note that TSA-based enforcement can deliver injunctions and fee awards without trial, lowering enforcement costs while maximising deterrence across the grower network.
Ag-biotech IP · TSA enforcement · InjunctionFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Bayer AG | Company | Agricultural biotech conglomerate — holder of US7838729B2 and US9944945B2 (GM soybean platform)Search in Eureka ↗ |
| Co-Plaintiff | Monsanto Technology, LLC | Company | Search in Eureka ↗ |
| Defendant | Greg Duffy | Individual | Individual farmer alleged to have saved and replanted patented GM soybean seed across three crop yearsSearch in Eureka ↗ |
| Plaintiff counsel | Anthony F. Blum | Attorney | Counsel for Bayer AGSearch in Eureka ↗ |
| Plaintiff counsel | Daniel C. Cox | Attorney | Counsel for Bayer AGSearch in Eureka ↗ |
| Plaintiff counsel | Jeffrey A. Masson | Attorney | Counsel for Bayer AGSearch in Eureka ↗ |
| Plaintiff counsel | Matthew S. Bober | Attorney | Counsel for Bayer AGSearch in Eureka ↗ |
| Plaintiff law firm | Thompson Coburn LLP (St Louis) | Law Firm | Representing Bayer AGSearch in Eureka ↗ |
| Defendant counsel | Wendell L. Hoskins , II | Attorney | Counsel for Greg DuffySearch in Eureka ↗ |
| Defendant law firm | Hoskins Law Office | Law Firm | Representing Greg DuffySearch in Eureka ↗ |
| Presiding judge | Judge John A. Ross | Judge | Missouri Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The verdict’s explicit reference to ‘knowingly and willfully’ infringing conduct across three named TSA periods (2020, 2021, 2022) is significant: it establishes a multi-year pattern rather than an isolated act, strengthening both the damages quantum and the permanent injunction’s justification. The dual basis — patent infringement and contract breach — means even if one ground were challenged on appeal, the other independently supports the judgment. The liquidated damages figure of $989,752.50 suggests per-unit or per-acre TSA penalties applied consistently, leaving Duffy limited appellate grounds to contest quantum.
US7838729B2 & US9944945B2 — GM Soybean Xtend Platform Patents
US7838729B2 (application No. 11/758659) covers soybean event MON89788 — the specific transgenic insertion event underlying Monsanto’s Roundup Ready 2 Xtend soybean trait — and methods for its detection. US9944945B2 (application No. 14/539923) claims chloroplast transit peptides that efficiently direct the dicamba monooxygenase (DMO) enzyme to chloroplasts in plant cells, enabling dicamba herbicide tolerance. Together, these patents protect the core biological and detection infrastructure of the Xtend soybean system, one of the most widely planted GM soybean platforms in North America.
Both patents sit at the centre of a high-value commercial platform. Any soybean variety carrying the MON89788 event or the DMO-targeting peptide construct requires a licence from Monsanto/Bayer. Competitors developing dicamba-tolerant or stacked-trait soybean events need to engineer around both patents or secure a licence. Given the breadth of the ‘729 detection claims, diagnostic tools used to identify MON89788 seed — including in grain handling and export contexts — may also require clearance. The patents’ combined scope makes independent development of a competing Xtend-equivalent platform technically and legally challenging.
Should you run an FTO against US7838729B2 and US9944945B2?
Any company or research institution developing transgenic soybean varieties with dicamba tolerance, herbicide-stacked traits, or event-specific detection assays should treat these two patents as priority FTO targets. The ‘729 patent’s event-specific detection claims are broad enough to implicate third-party seed purity testing, grain identity preservation programmes, and export certification workflows. The ‘945 patent’s chloroplast transit peptide claims cover a fundamental delivery mechanism — engineers working on DMO-based herbicide tolerance in any crop species should assess whether their construct design clears these claims.
PatSnap Eureka’s FTO Search Agent can map your construct or detection protocol against the full claim scope of both patents, identify prosecution history estoppel, and surface prior art that may limit enforceability. Eureka also monitors continuation and divisional filings in the same patent families — critical given Monsanto’s history of maintaining broad forward citation networks in agricultural biotech. Set up a portfolio watch to be alerted when related applications publish or when claims are amended in prosecution.
Run a freedom-to-operate analysis on US7838729B2 to assess your product’s exposure
Run FTO in Eureka →Similar GM Seed & Agricultural Biotech Patent Enforcement Cases
Explore related patent infringement actions involving GM soybean technology, TSA enforcement, and herbicide-tolerant trait patents in US district courts.
What this case signals for the agricultural biotech IP landscape
The Duffy judgment illustrates how GM seed IP is enforced end-to-end — from technology design through contractual licensing to courtroom recovery.
TSA liquidated damages clauses are litigation-ready enforcement tools
Bayer and Monsanto avoided the need to prove actual lost profits or established damages through expert testimony. The pre-agreed TSA liquidated damages provision produced a near-$1M judgment at summary judgment stage. Agricultural biotech companies should audit whether their own TSA frameworks contain equivalently enforceable damages provisions — and whether growers receive adequate notice of willfulness consequences.
Willfulness findings eliminate the most important defendant mitigation levers
A willfulness finding at summary judgment stage — without trial — is unusual and signals how clearly the evidence favoured plaintiffs. For IP teams, this underscores the importance of documented notice: cease-and-desist correspondence, audit programmes, and TSA acknowledgements all build a willfulness record that forecloses the defendant’s ability to argue good-faith belief in non-infringement.
Bayer v Greg — key questions answered
Bayer AG and Monsanto Technology LLC asserted two patents: US7838729B2, covering soybean event MON89788 and detection methods, and US9944945B2, covering chloroplast transit peptides for DMO targeting. Both underpin the Roundup Ready 2 Xtend soybean platform. The court found Duffy liable for infringing both patents.
Judge John A. Ross entered a judgment of $989,752.50 in liquidated damages against Caleb Duffy. This figure derived from pre-agreed liquidated damages provisions in the Technology Stewardship Agreements signed by Duffy for the 2020, 2021, and 2022 crop years. The court also awarded attorney fees to plaintiffs, with the amount subject to further proceedings.
A Technology Stewardship Agreement (TSA) is a licence contract between Monsanto/Bayer and growers authorising use of patented GM seed technology. TSAs typically include liquidated damages clauses for misuse such as seed saving. In this case, the TSAs Duffy signed for 2020–2022 provided the damages formula and contractual fee-shifting that allowed plaintiffs to recover $989,752.50 and attorney fees without needing to prove actual economic loss.
The court permanently enjoined Duffy from making, using, saving, planting, selling, offering to sell, importing, or transferring any soybean or other seed containing Bayer and Monsanto’s patented biotechnologies without express written permission. The injunction also prohibits Duffy from applying unapproved dicamba-based herbicide formulations to Xtend crops, including applications after applicable deadlines.
Yes. The court found at summary judgment that Duffy knowingly and willfully infringed the ‘945 and ‘729 patents. A willfulness finding indicates the defendant had actual notice of the patent rights and deliberately continued infringing conduct. While the court here awarded liquidated damages per the TSA formula, willfulness also supported the attorney fee entitlement and forecloses certain equitable defences Duffy might otherwise raise on appeal.
PatSnap Eureka searches patents and litigation data to answer instantly.